Neurological Institute Outcomes
Headache
OnabotulinumtoxinA Therapy for Headache
Outcomes Following OnabotulinumtoxinA Treatment (N = 1856)
2021
HIT-6 = Headache Impact Test, PHQ-9 = Patient Health Questionnaire, PROMIS = Patient Reported Outcome Measurement Information System
In 2021, the outcomes of 1856 headache patients who were treated with onabotulinumtoxinA were reviewed. More than 70% had improved or stable HIT-6 scores¹ and approximately 90% reported improved or stable PROMIS pain² and/or depression scores.³